Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose

Wei Hao, Steven Gitelman, Linda A. DiMeglio, +2

Diabetes Care

High residual C-peptide likely contributes to glycemic control in type 1 diabetes

Michael R. Rickels, Carmella Evans‐Molina, Henry T. Bahnson, +10

Journal of Clinical Investigation

Residual C-peptideInsulin SignalingGastrointestinal Peptide HormoneMetabolic SyndromeType 1 +14

Low-dose interleukin 1 and tumor necrosis factor individually stimulate insulin release but in combination cause suppression

Vivek Mehta, Wei Hao, Barbara Brooks‐Worrell, +1

European Journal of Endocrinology

Serological surveillance for Penicillium marneffei infection in HIV-infected patients during 2004–2011 in Guangzhou, China

Y. Wang, Huifang Xu, Zhigang Han, +8

Clinical Microbiology and Infection

Clinical Infectious DiseaseClinical InfectionHivSerological SurveillanceHiv-infected Patients +2

MiR‐148a regulates bone marrow mesenchymal stem cells‐mediated fracture healing by targeting insulin‐like growth factor 1

Hongzhi Liu, Hao Su, Xin Wang, +1

Journal of Cellular Biochemistry

Bone RepairBiomedical EngineeringStem Cell BiologyOsteoporosisOrthopaedic Surgery +17

Genetics Coming of Age in Type 1 Diabetes

Karen Cerolsaletti, Wei Hao, Carla J. Greenbaum

Diabetes Care

GeneticsGenetic EpidemiologyImmunologyImmune SystemGenome-wide Association Studies +17

Development of monoclonal antibody-based galactomannoprotein antigen-capture ELISAs to detect Aspergillus fumigatus infection in the invasive aspergillosis rabbit models

Z.-Y. Wang, Jian‐Piao Cai, Wei Hao, +6

European Journal of Clinical Microbiology & Infectious Diseases

Aspergillus Fumigatus InfectionPathogenesisImmunologySerologic TestingAntibody Screening +2

Assessment of β Cell Mass and Function by AIRmax and Intravenous Glucose in High-Risk Subjects for Type 1 Diabetes

Wei Hao, Alyssa Wookwyk, Craig A. Beam, +3

The Journal of Clinical Endocrinology & Metabolism

Pooled week 48 safety and efficacy results from the ECHO and THRIVE phase III trials comparing TMC278 vs EFV in treatment‐naïve, HIV‐1‐infected patients

Cal Cohen, Pedro Cahn, Bonaventura Clotet, +10

Journal of the International AIDS Society

Treatment And PreventionHuman RetrovirusWeek 48Tmc278 Vs EfvHiv Infection +11

Radioimmunoassay for Glutamic Acid Decarboxylase-65

Wei Hao, Terri Daniels, Daniël Pipeleers, +4

Diabetes Technology & Therapeutics